| Androgen receptor and androgen-dependent gene expression in lung L Mikkonen, P Pihlajamaa, B Sahu, FP Zhang, OA Jänne Molecular and cellular endocrinology 317 (1-2), 14-24, 2010 | 276 | 2010 |
| FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells B Sahu, M Laakso, P Pihlajamaa, K Ovaska, I Sinielnikov, S Hautaniemi, ... Cancer research 73 (5), 1570-1580, 2013 | 274 | 2013 |
| Tissue‐specific pioneer factors associate with androgen receptor cistromes and transcription programs P Pihlajamaa, B Sahu, L Lyly, V Aittomäki, S Hautaniemi, OA Jänne The EMBO journal 33 (4), 312-326, 2014 | 138 | 2014 |
| Determinants of receptor-and tissue-specific actions in androgen signaling P Pihlajamaa, B Sahu, OA Jänne Endocrine reviews 36 (4), 357-384, 2015 | 128 | 2015 |
| Sequence determinants of human gene regulatory elements B Sahu, T Hartonen, P Pihlajamaa, B Wei, K Dave, F Zhu, E Kaasinen, ... Nature Genetics 54 (3), 283-294, 2022 | 123 | 2022 |
| The phytoestrogen genistein is a tissue-specific androgen receptor modulator P Pihlajamaa, FP Zhang, L Saarinen, L Mikkonen, S Hautaniemi, ... Endocrinology 152 (11), 4395-4405, 2011 | 66 | 2011 |
| Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo B Sahu, P Pihlajamaa, V Dubois, S Kerkhofs, F Claessens, OA Jänne Nucleic acids research 42 (7), 4230-4240, 2014 | 61 | 2014 |
| Identification of several potential chromatin binding sites of HOXB7 and its downstream target genes in breast cancer H Heinonen, T Lepikhova, B Sahu, H Pehkonen, P Pihlajamaa, ... International Journal of Cancer 137 (10), 2374-2383, 2015 | 48 | 2015 |
| Contribution of allelic imbalance to colorectal cancer K Palin, E Pitkänen, M Turunen, B Sahu, P Pihlajamaa, T Kivioja, ... Nature communications 9 (1), 3664, 2018 | 38 | 2018 |
| Human cell transformation by combined lineage conversion and oncogene expression B Sahu, P Pihlajamaa, K Zhang, K Palin, S Ahonen, A Cervera, ... Oncogene 40 (36), 5533-5547, 2021 | 16 | 2021 |
| WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas M Aavikko, E Kaasinen, N Andersson, N Pentinmikko, P Sulo, I Donner, ... Human molecular genetics 30 (24), 2429-2440, 2021 | 9 | 2021 |
| A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites P Pihlajamaa, O Kauko, B Sahu, T Kivioja, J Taipale Nature Biotechnology 41 (2), 197-203, 2023 | 3 | 2023 |
| Cellular transformation by combined lineage conversion and oncogene expression B Sahu, P Pihlajamaa, K Zhang, K Palin, S Ahonen, A Cervera, ... | 2 | 2019 |
| Characterization of an androgen-responsive, ornithine decarboxylase-related protein in mouse kidney KM Silander, P Pihlajamaa, B Sahu, OA Jänne, LC Andersson Bioscience Reports 37 (4), BSR20170163, 2017 | 2 | 2017 |
| Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes D Patel, V Tiusanen, P Pihlajamaa, B Sahu bioRxiv, 2024.01. 15.575744, 2024 | 1 | 2024 |
| Identifying critical transcriptional targets of the MYC oncogene using a novel competitive precision genome editing (CGE) assay P Pihlajamaa, O Kauko, B Sahu, T Kivioja, J Taipale bioRxiv, 2021.09. 17.460746, 2021 | 1 | 2021 |
| SUMO-1 Function in Regulation of Energy Metabolism In Vivo. L Mikkonen, P Pihlajamaa, J Hirvonen, OA Janne ENDOCRINE REVIEWS 31 (3), 2010 | 1 | 2010 |
| Lineage-specific oncogenes drive growth of major forms of human cancer using common downstream mechanisms O Kauko, M Turunen, P Pihlajamaa, A Häkkinen, RML Queiroz, ... bioRxiv, 2022.09. 27.509636, 2022 | | 2022 |
| Defining the molecular state of human cancer B Sahu, P Pihlajamaa, K Zhang, K Palin, S Ahonen, A Cervera, ... bioRxiv, 525600, 2019 | | 2019 |
| Direct conversion of human fibroblasts to liver cancer cells B Sahu, P Pihlajamaa, K Zhang, A Cervera, S Hautaniemi, J Taipale bioRxiv, 525600, 2019 | | 2019 |
